|
Volumn 16 Suppl A, Issue , 2009, Pages
|
Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial).
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETIC ACID DERIVATIVE;
ANTIASTHMATIC AGENT;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
GLUCOCORTICOID;
MONTELUKAST;
QUINOLINE DERIVATIVE;
ADOLESCENT;
ADULT;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DELAYED RELEASE FORMULATION;
DOSE RESPONSE;
DRUG COMBINATION;
FEMALE;
FOLLOW UP;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PERENNIAL RHINITIS;
PHASE 4 CLINICAL TRIAL;
PROSPECTIVE STUDY;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ACETATES;
ADMINISTRATION, INHALATION;
ADOLESCENT;
ADRENERGIC BETA-AGONISTS;
ADULT;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
DELAYED-ACTION PREPARATIONS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GLUCOCORTICOIDS;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
QUESTIONNAIRES;
QUINOLINES;
RHINITIS, ALLERGIC, PERENNIAL;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 76949100766
PISSN: None
EISSN: 19167245
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (49)
|
References (0)
|